CDD-2211
CDD-2211 is a STK33 inhibitor, with a Kd of 0.018 nM and an IC50 of 5 nM. CDD-2211 has relatively weak inhibitory effects on off-target kinases, with IC50 values of 115 nM for CLK1, 48 nM for CLK2, 187 nM for CLK4, and 78 nM for RET. CDD-2211 can be used for the study of contraception[1].
Product Specifications
CAS Number
[3086535-51-2]
UNSPSC
12352005
Target
RET; STK33
Related Pathways
Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK
Field of Research
Others
Smiles
O=C(N1C[C@@H](CC1)N(C)C)C2=CC=C3C(C(C#CC4=C(C5=CC=CC=C5)C=CC=C4)=NN3)=C2
Molecular Formula
C28H26N4O
Molecular Weight
434.53
References & Citations
[1]Ku AF, et al. Reversible male contraception by targeted inhibition of serine/threonine kinase 33. Science. 2024 May 24;384 (6698) :885-890.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1469334-01 0.02 mg (E-Coli)
Recombinant Alcanivorax borkumensis Argininosuccinate lyase (argH)
Ask
View Details 
MBS1469334-02 0.02 mg (Yeast)
Recombinant Alcanivorax borkumensis Argininosuccinate lyase (argH)
Ask
View Details 
MBS1469334-03 0.1 mg (E-Coli)
Recombinant Alcanivorax borkumensis Argininosuccinate lyase (argH)
Ask
View Details MBS1469334-04 0.1 mg (Yeast)
Recombinant Alcanivorax borkumensis Argininosuccinate lyase (argH)
Ask
View Details MBS1469334-05 0.02 mg (Baculovirus)
Recombinant Alcanivorax borkumensis Argininosuccinate lyase (argH)
Ask
View Details MBS1469334-06 0.02 mg (Mammalian-Cell)
Recombinant Alcanivorax borkumensis Argininosuccinate lyase (argH)
Ask
View Details